Aradigm Corporation (ARDM)
(Delayed Data from OTC)
$0.12 USD
0.00 (0.00%)
Updated Feb 19, 2019 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ARDM]
Reports for Purchase
Showing records 1 - 14 ( 14 total )
Industry: Medical - Drugs
ValuEngine Detailed Valuation Report for ARDM
Provider: ValuEngine, Inc
Industry: Medical - Drugs
Industry: Medical - Drugs
Announces Issuance of First US Patent and Selects Pulmaquin- for Phase III Development
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Industry: Medical - Drugs
Announces Issuance of First US Patent and Selects Pulmaquin -for Phase III Development
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Industry: Medical - Drugs
3Q11 Earnings Release: Awaiting Upcoming Key Milestones
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Industry: Medical - Drugs
3Q11 Earnings Release: Awaiting Upcoming Key Milestones
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Industry: Medical - Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Drugs
Transfer of Coverage: Maintaining a Market Outperform Rating
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Drugs
Transfer of Coverage: Maintaining a Market Outperform Rating
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Drugs
Industry: Medical - Drugs
We are initiating coverage of Aradigm with a Market Outperform rating and a $0.45 price target
Provider: RODMAN & RENSHAW, CO.
Analyst: HIGGINS M
Industry: Medical - Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Drugs
We are initiating coverage of Aradigm with a Market Outperform rating and a $0.45 price target
Provider: RODMAN & RENSHAW, CO.
Analyst: HIGGINS M
Industry: Medical - Dental Supplies
A FIVE STAR PATENTVEST IP VALUE COMPANY - 2011 "BEST AND BRIGHTEST" PATENTVEST REPORTS
Provider: MDB CAPITAL GROUP LLC
|